---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-269454"
form_type: "8-K"
ticker: "LMAT"
cik: "0001158895"
company_name: "LEMAITRE VASCULAR INC"
filed_at: "2025-11-06T23:59:59+00:00"
generated_at: "2026-05-16T23:22:29.797497+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# LeMaitre Q3 sales $61.0M (+11%), EPS $0.75 (+54%); raises FY guidance

## Summary
- Q3 sales $61.0M (+11% YoY, +12% organic); Grafts +23%, Shunts +18%, Artegraft +33%.
- GAAP diluted EPS $0.75 (+54%); adjusted EPS $0.62 (+27%).
- Adjusted gross margin 70.8% (up 300 bps) on pricing and manufacturing efficiencies.
- Full-year 2025 guidance raised: sales $247-249M, EPS $2.48-2.53 (midpoint +30%).
- Quarterly dividend $0.20/share, payable Dec 4 to holders of record Nov 20.

## SEC filing metadata
- accession: 0001193125-25-269454
- form_type: 8-K
- ticker: LMAT
- cik: 0001158895
- company_name: LEMAITRE VASCULAR INC
- filed_at: 2025-11-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1158895/000119312525269454/0001193125-25-269454-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1158895/000119312525269454/d35939d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-269454
- JSON: https://secwatch.observer/filing/0001193125-25-269454.json
- Plain text: https://secwatch.observer/filing/0001193125-25-269454.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.